View Cart (0 items)


Biogen, Acorda MS Drug Receives Conditional European OK

July 26, 2011
MarketWatch reports, Biogen Idec Inc. has received conditional approval of multiple sclerosis pill Fampyra in Europe, after a positive recommendation in May that followed an earlier rejection. The drug, developed
Read More

Pfizer Sues Apotex in US Over Generic Version of Lyrica

July 11, 2011
Pfizer Inc., the world’s largest drugmaker, accused Apotex Inc. in a lawsuit of infringing two U.S. patents for the nerve-pain drug Lyrica, reports Bloomberg. Apotex, based in Toronto, plans
Read More

GlaxoSmithKline to Pay 37 States $41 Million Over Faulty Drugs

June 27, 2011
British drugmaker GlaxoSmithKline PLC has reached a $40.75 million settlement with 37 states for selling potentially faulty and contaminated medicines produced at its former Puerto Rico factory during the last
Read More

USDA Takes Action Against Drug Manufacturer and Distributor

June 20, 2011
PRNewswire reports, the U.S. Food and Drug Administration announced that a consent decree of condemnation, forfeiture and permanent injunction has been filed against H&P Industries Inc., The Triad Group
Read More

Major Drug Companies Cut Vaccine Prices in Developing Countries

June 6, 2011
International Business Times reports, a group of major western pharmaceutical companies announced that they will significantly reduce the prices they charge for vaccines in the developing world. Merck & Co.,
Read More

Johnson & Johnson Acquiring OTC of J B Chemicals of Russia

May 23, 2011
The Associated Press reports, Johnson & Johnson said that its Cilag GmbH unit will expand its business in Russia by buying the over-the-counter brands of J B Chemicals & Pharmaceuticals
Read More

Pfizer Seeks US, Japan Approval of Cancer Drug

May 17, 2011
The Associated Press reports, Pfizer Inc. said that the Food and Drug Administration accepted its application for the experimental lung cancer treatment crizotinib, one of its key drug candidates. Pfizer
Read More

Pfizer Weighs Sale, Spin-off of Units

May 3, 2011
Chief Executive Officer Ian Read said he is reviewing the possible sale of four divisions with $18.3 billion in annual revenue, according to Bloomberg. Read, who took control of Pfizer
Read More

Linde Builds Large Hydrogen and Synthesis Gas Plant in China

May 3, 2011
Reuters reports, the Linde Group will build and operate a large hydrogen and synthesis gas plant in the Chongqing Chemical Park in Western China in a joint enterprise with Chongqing
Read More

A. Schulman Adds Manufacturing Line in Brazilian Facility

April 18, 2011
A. Schulman, Inc. announced that it will add one manufacturing line in its Sao Paulo, Brazil plant to accommodate increased demand for the company''s masterbatch and engineered plastics products, reports
Read More